Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
3.300
+0.180 (5.77%)
Apr 8, 2026, 10:19 AM EDT - Market open
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $417.66 million as of April 8, 2026. Its market cap has increased by 234.43% in one year.
Market Cap
417.66M
Enterprise Value
321.49M
1-Year Change
234.43%
Ranking
Category
Stock Price
$3.30
Market Cap Chart
Since March 26, 2021, Nautilus Biotechnology's market cap has increased from $117.04M to $417.66M, an increase of 256.87%. That is a compound annual growth rate of 28.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 394.88M | 60.33% |
| Dec 31, 2025 | 246.29M | 16.76% |
| Dec 31, 2024 | 210.95M | -43.54% |
| Dec 29, 2023 | 373.66M | 66.44% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.18M | 449.56% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aura Biosciences | 425.32M |
| Eupraxia Pharmaceuticals | 416.76M |
| XOMA Royalty | 412.05M |
| Century Therapeutics | 406.17M |
| Ginkgo Bioworks Holdings | 396.97M |
| Enanta Pharmaceuticals | 389.73M |
| Neumora Therapeutics | 387.75M |
| Rocket Pharmaceuticals | 379.75M |